Travis E Grotz
Overview
Explore the profile of Travis E Grotz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
91
Citations
1650
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Leiting J, Alva-Ruiz R, Yonkus J, Abdelrahman A, Lynch I, Carlson D, et al.
Ann Surg Oncol
. 2025 Mar;
PMID: 40067610
Background: Patients with pancreatic ductal adenocarcinoma (PDAC) commonly have occult metastatic dissemination and current standard staging methods have significant limitations in identifying these patients. A clinically available assay allows for...
2.
Wu G, Standring O, King D, Gholami S, Devoe C, Thiels C, et al.
Curr Oncol
. 2025 Feb;
32(2).
PMID: 39996904
The peritoneum is the second most common site of metastasis in patients with pancreatic ductal adenocarcinoma (PDAC). Up to half of all patients that undergo curative-intent resection eventually develop peritoneal...
3.
Matzek L, Otta J, Hofer R, Sims C, Kerfeld M, Stewart T, et al.
Ann Thorac Surg Short Rep
. 2025 Jan;
2(3):520-523.
PMID: 39790392
Pleural extension of pseudomyxoma peritonei is rare, and treatment demands multidisciplinary care. Perioperative management during cytoreductive surgery and hyperthermic intrathoracic chemotherapy challenges anesthesiology and surgical teams in unique ways. Hemodynamic,...
4.
Thiels C, Grotz T
J Surg Oncol
. 2024 Nov;
130(6):1257-1262.
PMID: 39552018
Peritoneal spread is a frequent cause of metastasis in both the synchronous and metachronous settings for patients with pancreatic cancer. Recent improvements in systemic chemotherapy for pancreatic cancer may now...
5.
Christenson R, Sood S, Vierkant R, Schupack D, Boardman L, Grotz T
J Gastrointest Surg
. 2024 Aug;
28(11):1890-1896.
PMID: 39214399
Background: Gastric polyposis is common in familial adenomatous polyposis (FAP) syndrome. However, the incidence and risk factors for gastric cancer (GC) are unclear. We aimed to evaluate the incidence of...
6.
Lohani K, Sonani H, Buckarma E, Lee H, Vierkant R, Thiels C, et al.
J Gastrointest Surg
. 2024 Aug;
28(11):1906-1911.
PMID: 39209560
Background: Low-grade appendiceal mucinous neoplasms (LAMNs) can progress to pseudomyxoma peritonei (PMP). The incidence and risk factors for recurrence are unclear, and there is a lack of consensus on the...
7.
Riely G, Wood D, Ettinger D, Aisner D, Akerley W, Bauman J, et al.
J Natl Compr Canc Netw
. 2024 May;
22(4):249-274.
PMID: 38754467
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Non-Small Cell Lung Cancer (NSCLC) provide recommendations for the treatment of patients with NSCLC, including diagnosis, primary disease management, surveillance...
8.
Gudmundsdottir H, Fogliati A, Grotz T, Thiels C, Warner S, Smoot R, et al.
Ann Surg Oncol
. 2024 Apr;
31(8):5370-5376.
PMID: 38689169
Background: Cytoreductive hepatectomy can improve survival and symptoms of hormonal excess in patients with small intestinal neuroendocrine tumor (siNET) liver metastases, but whether to proceed when peritoneal metastases are encountered...
9.
Stevenson J, Ettinger D, Wood D, Aisner D, Akerley W, Bauman J, et al.
J Natl Compr Canc Netw
. 2024 Mar;
22(2):72-81.
PMID: 38503043
Mesothelioma is a rare cancer that originates from the mesothelial surfaces of the pleura and other sites, and is estimated to occur in approximately 3,500 people in the United States...
10.
Fogliati A, Zironda A, Fiorentini G, Adjei S, Amro A, Starlinger P, et al.
Ann Surg Oncol
. 2024 Feb;
31(4):2632-2639.
PMID: 38319513
Background: The management of invasive intraductal papillary mucinous cystic neoplasm (I-IPMN) does not differ from de novo pancreatic ductal adenocarcinoma (PDAC); however, I-IPMNs are debated to have better prognosis. Despite...